Finding out you have a lung nodule can be alarming, but knowing when to worry about lung nodules — and when not to — can save you significant anxiety. A lung nodule is a small, round or oval growth in the lung, typically discovered incidentally during a CT scan performed for another reason. The American Thoracic Society notes that a large share of adults who undergo chest CT scans have at least one lung nodule, and the vast majority — well over 90 percent — are benign.
Quick summary: Most lung nodules are not cancer. Still, a nodule found on imaging should not be ignored — it needs the follow-up your doctor recommends, based on frameworks like the Fleischner Society guidelines (for incidental nodules) and Lung-RADS (for screening CT). Size is the biggest single factor, along with shape, density, growth, and your smoking history. Report new symptoms such as coughing up blood, unexplained weight loss, or a worsening cough. This article is educational and does not replace advice from your own clinician.
Still, some nodules do turn out to be early-stage lung cancer. Understanding the factors that distinguish a harmless nodule from a concerning one helps you have informed conversations with your doctor and make confident decisions about follow-up care. The single most important thing you can do is keep the follow-up scans your doctor schedules, because catching change early is what makes treatment most effective.
What Exactly Is a Lung Nodule?
A lung nodule (also called a pulmonary nodule or “spot on the lung”) is a small area of increased density measuring up to 30 millimeters (about 1.2 inches) across. Anything larger than 30 mm is classified as a lung mass rather than a nodule — and masses carry a higher probability of malignancy.
Nodules can form from many causes. Previous infections like tuberculosis, histoplasmosis, or pneumonia often leave behind small scars or granulomas that show up as nodules on imaging. Inflammation from conditions like rheumatoid arthritis or sarcoidosis can also produce them. In a smaller percentage of cases, a nodule represents an early-stage cancer or a metastasis from cancer elsewhere in the body.
According to the Mayo Clinic, the likelihood of a lung nodule being cancerous depends heavily on its size, shape, density, and your individual risk factors. No single feature decides the answer; doctors weigh them together.
Size Matters: The Nodule Size Risk Scale
Size is the single most important factor in determining whether a lung nodule is concerning. Research and guideline frameworks, including the Fleischner Society 2017 guidelines, have established clear size-risk relationships that still guide practice. The percentages below are general estimates; your doctor individualizes them using your risk factors.
Nodules Under 6 mm
These tiny nodules carry a cancer risk of less than about 1 percent in patients without significant risk factors. The Fleischner guidelines recommend no routine follow-up for solid nodules under 6 mm in low-risk patients. For high-risk patients (heavy smokers, family history of lung cancer), a single follow-up CT at around 12 months may be suggested.
Nodules 6-8 mm
Risk rises modestly in this range for solid nodules. Guidelines typically recommend follow-up CT scans at around 6 to 12 months, with a second scan at roughly 18 to 24 months if the nodule remains stable. Stability over a two-year period for a solid nodule is generally considered reassuring.
Nodules 8-15 mm
This is where concern increases meaningfully. Nodules in this size range carry a higher malignancy risk that depends heavily on other characteristics. Your doctor will often recommend a PET scan or a shorter-interval follow-up CT at about 3 months, and biopsy may be discussed, especially if the nodule has suspicious features.
Nodules 15-30 mm
Larger nodules carry a substantially higher risk, with malignancy rates rising as they approach 30 mm. Most pulmonologists will recommend a PET scan, biopsy, or both. Surgical removal may be considered even without a tissue diagnosis if imaging is highly suspicious and your risk is high.
Size and Follow-Up at a Glance
| Solid nodule size | General concern level | Typical next step |
|---|---|---|
| Under 6 mm | Very low | Often no routine follow-up (low risk); one CT at ~12 months if high risk |
| 6-8 mm | Low to modest | Follow-up CT at ~6-12 months, then again if stable |
| 8-15 mm | Intermediate | Short-interval CT, PET scan, or biopsy discussion |
| 15-30 mm | Higher | PET scan and/or biopsy; surgery if highly suspicious |
This table is a simplified overview for solid nodules; ground-glass and part-solid nodules follow different schedules, and your doctor sets the actual plan.
Shape and Density: Beyond Size
Size alone does not tell the full story. Two nodules of identical size can carry very different risk profiles based on their appearance on CT.
Solid vs. ground-glass vs. part-solid. Solid nodules appear white and opaque on CT. Ground-glass nodules (also called ground-glass opacities, or GGOs) look hazy, like frosted glass. Part-solid nodules have both components. Part-solid nodules can carry a notably high malignancy risk once they exceed a small size, which is reflected in the American College of Radiology’s Lung-RADS system (updated in its 2022 version for screening CT). Pure ground-glass nodules tend to grow very slowly and, when malignant, are often low-grade cancers with an excellent prognosis — but they may need longer surveillance because of that slow growth.
Edges and margins. Smooth, well-defined edges suggest a benign process like a granuloma. Irregular, spiculated (spiky) margins are more concerning for malignancy. A “corona radiata” — fine lines extending outward from the nodule — is considered particularly suspicious.
Calcification patterns. Certain calcification patterns are reliably benign. A nodule that is completely calcified, has a central “bull’s-eye” pattern, or shows “popcorn” calcification is almost certainly not cancerous. Eccentric or stippled calcification, however, does not rule out malignancy.
Your Personal Risk Factors
When evaluating a lung nodule, your doctor considers your individual risk profile alongside the nodule’s imaging characteristics. Several factors significantly influence the probability of malignancy.
Smoking history is the most powerful risk factor. Current and former smokers face substantially higher risk, and the risk correlates with pack-years (packs per day multiplied by years smoked). Someone with a 30 pack-year history has a meaningfully different risk profile than a never-smoker with the same nodule.
Age matters considerably. A 6 mm nodule in a 30-year-old nonsmoker is far less concerning than the same nodule in a 70-year-old former smoker. Lung cancer rates increase with age, rising notably after age 50 according to the CDC.
Prior cancer history changes the calculus. If you have previously been treated for cancer — particularly cancers that commonly spread to the lungs (breast, colon, kidney, melanoma) — even small nodules may warrant closer monitoring.
Occupational and environmental exposures to asbestos, radon, uranium, or certain chemicals increase lung cancer risk and should be factored into nodule evaluation. A family history of lung cancer also modestly elevates risk.
Growth Rate: The Key Follow-Up Metric
When follow-up imaging is recommended, your doctor is looking for one critical data point: has the nodule grown? Growth is often expressed as “doubling time” — how long it takes the nodule’s volume to double.
Malignant solid nodules typically have a volume doubling time somewhere between roughly 100 and 400 days. Very rapid growth (doubling in under about a month) more often suggests infection or inflammation than cancer. Very slow growth (doubling time beyond about 500 days) is more common with benign processes or very indolent cancers.
Here is a counterintuitive point: a nodule does not need to visibly “grow” much in diameter to double in volume. Because volume scales with the cube of the radius, a nodule that grows from 8 mm to about 10 mm in diameter has increased in volume by roughly 95 percent — nearly doubling. This is why precise measurement on serial CT scans matters, and why your doctor may use specialized software to track volume changes. It is also why keeping every scheduled scan is so important: small changes are only detectable by comparison over time.
What Happens Next: Surveillance, Biopsy, or Surgery
Based on the nodule’s characteristics and your risk factors, your doctor will typically recommend one of three paths.
Surveillance (Watch and Wait)
For small, low-risk nodules, serial CT scans at defined intervals are the standard approach. If a solid nodule remains stable over two years (or a ground-glass nodule over a longer window, often around five years), it is generally considered benign. No treatment is needed — just continued monitoring. The large majority of small nodules followed with surveillance prove to be benign.
PET Scan or Biopsy
For intermediate-risk nodules (often 8 mm or larger), a PET scan can help assess metabolic activity. Cancer cells tend to be metabolically active and “light up” on PET. However, PET scans can produce false positives (infections and inflammation also light up) and false negatives (some slow-growing cancers do not show significant uptake). A CT-guided needle biopsy provides tissue for definitive analysis but carries a small risk of pneumothorax (a partial lung collapse), a recognized complication described by the National Library of Medicine; most cases are manageable and many resolve on their own or with a small chest tube.
Surgical Removal
For high-risk nodules or those confirmed as cancer by biopsy, surgical removal is often recommended. Video-assisted thoracoscopic surgery (VATS) is minimally invasive and allows removal of the nodule along with a margin of healthy tissue. If the nodule proves to be early-stage lung cancer, surgery can be curative, with strong five-year survival rates for stage I disease — another reason early detection through diligent follow-up is so valuable.
Lung Cancer Screening: Who Qualifies
Separate from evaluating an incidental nodule, structured lung cancer screening can catch cancer early in high-risk people. The U.S. Preventive Services Task Force recommends annual low-dose CT screening for adults aged 50 to 80 who have a 20 pack-year smoking history and who currently smoke or have quit within the past 15 years. Screening should stop once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability to have lung surgery. If you think you may qualify, ask your doctor, and see our lung cancer screening guide for more detail.
When to See a Doctor
If you have been told you have a lung nodule, the most important step is following through with the recommended follow-up imaging. Missing a scheduled surveillance CT can mean losing the window to catch growth early. Do not assume that no news is good news — confirm your next scan date and put it on the calendar.
Contact your doctor sooner than your scheduled follow-up if you develop new symptoms such as a persistent or worsening cough, coughing up blood, unexplained shortness of breath, chest pain, or unintentional weight loss. While these symptoms have many possible causes, they deserve evaluation in the context of a known lung nodule.
Seek emergency care now: Call 911 or go to the nearest emergency room if you experience sudden severe chest pain, significant difficulty breathing, or you are coughing up large amounts of blood. See a doctor promptly (do not wait for a routine appointment) for coughing up any blood, a cough that is new or getting worse over weeks, unexplained weight loss, or worsening breathlessness.
Frequently Asked Questions
Can lung nodules go away on their own?
Yes, some can. Nodules caused by infections or inflammation may shrink or disappear entirely as the underlying condition resolves. This is a reassuring sign — a nodule that has decreased in size on follow-up imaging is very unlikely to be cancer. Your doctor may still recommend one additional follow-up scan to confirm continued stability or resolution.
Should I get a second opinion about my lung nodule?
If your nodule falls in the intermediate category (roughly 8 to 15 mm, or with mixed features), seeking input from a pulmonologist or thoracic specialist is reasonable, especially if your primary care doctor is uncertain about the best next step. Having your CT images reviewed by a radiologist who specializes in chest imaging can also add valuable perspective.
Does anxiety about lung nodules affect outcomes?
Research has documented significant anxiety and distress among patients with incidental lung nodules, sometimes called “scanxiety.” While this anxiety is understandable, the statistical odds are strongly in your favor — most nodules are benign. Talking with your doctor about your specific risk level can help calibrate your concern appropriately, and keeping to the follow-up schedule is the most productive way to channel that worry.
Are multiple lung nodules more concerning than a single one?
Not necessarily. Multiple small nodules are actually more commonly caused by prior infections (especially fungal infections like histoplasmosis in certain regions) or inflammatory conditions. A single dominant nodule with suspicious features is often more concerning than several scattered small nodules. However, in patients with a known cancer history, multiple new nodules may suggest metastatic disease and warrant prompt evaluation.
How often do lung nodules turn out to be cancer?
Among all incidentally discovered lung nodules, only a small minority are malignant, and the rate varies dramatically by size and risk factors. For nodules under 6 mm in low-risk patients, the rate is well under 1 percent. For large nodules in high-risk patients, the rate is much higher. Your doctor can help you understand where your specific nodule falls on that spectrum.
Practical Takeaway
Most lung nodules are benign, and the vast majority will never require anything beyond routine follow-up imaging. Focus on the factors within your control: attend all scheduled follow-up appointments, give your doctor an accurate smoking and exposure history, and report any new respiratory symptoms promptly. If you currently smoke, quitting remains the single most impactful step you can take for your lung health, and it also changes your future screening eligibility over time. For a broader look at health warning signs and related conditions, visit our medical conditions guide. Use this article to prepare for a conversation with your clinician rather than as a substitute for personalized medical advice.